Offer - Urjas Oil for just ₹ 1
Lamriga 50 Tablet DT is a prescription drug, available for use as Tablet. It is primarily used for the treatment of Seizures. Other than this, Lamriga 50 Tablet DT has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Lamriga 50 Tablet DT depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Lamriga 50 Tablet DT as well, which are listed below. Usually, these side effects of Lamriga 50 Tablet DT go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Lamriga 50 Tablet DT has a Moderate effect for pregnant women and Moderate effect on lactating mothers. Warnings related to Lamriga 50 Tablet DT's effects on the liver, heart and kidney, if any, have been listed below.
Lamriga 50 Tablet DT is not recommended if you suffer from certain medical conditions as it can have adverse effects. Depression are examples of such conditions. The section on Lamriga 50 Tablet DT contraindications lists all such conditions.
Drug reaction of Lamriga 50 Tablet DT with other medicines has been reported. Refer to the list below for further details.
You should also be aware that Lamriga 50 Tablet DT is not safe while driving, and is not addiction.
Lamriga 50 Tablet DT is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Lamriga 50 Tablet DT safe for pregnant women?
Lamriga may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Lamriga again without your doctor's advice.
Is the use of Lamriga 50 Tablet DT safe during breastfeeding?
Lamriga can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Lamriga 50 Tablet DT on the Kidneys?
Lamriga may have mild side effects on the kidneys.
What is the effect of Lamriga 50 Tablet DT on the Liver?
Lamriga may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Lamriga 50 Tablet DT on the Heart?
Using Lamriga does not have any harmful effects on the heart.
If you are suffering from any of the following diseases, you should not take Lamriga 50 Tablet DT unless your doctor advises you to do so -
Is this Lamriga 50 Tablet DT habit forming or addictive?
No, there is no any evidence that Lamriga 50 Tablet DT is addictive.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Lamriga 50 Tablet DT. So it is best to avoid driving.
Is it safe?
Yes, but take Lamriga 50 Tablet DT only as per medical advice.
Is it able to treat mental disorders?
Yes, this Lamriga 50 Tablet DT works for mental disorders.
Interaction between Food and Lamriga 50 Tablet DT
Taking Lamriga 50 Tablet DT with food is safe.
Interaction between Alcohol and Lamriga 50 Tablet DT
Consumption of alcohol and Lamriga 50 Tablet DT together may have severe effects on your health.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 742- 744
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 419
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lamictal (lamotrigine)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lamitan (lamotrigine)